It was a good question regarding today's closing sp. The cap raise had been for long enough to allow everyone interested in cdc to participate. It was even exended once... Where was the buying pressure coming from? My only guess is from Chinese citisens not being able buy at Ipo but allowed to buy after listing... Was it available to Australian investors only? Some of the Chinese Ipo's are getting good support post listing like whone or dfm. Good luck guys. Well done to those who got a stag. If it performs long term similarly to dfm than happy days for holders. I was too scared to take a plunge on this one....
CDC Price at posting:
25.0¢ Sentiment: None Disclosure: Not Held
